Page last updated: 2024-08-24

tepoxalin and cyclosporine

tepoxalin has been researched along with cyclosporine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chourmouzis, E; Fung-Leung, WP; Lau, CY; Panakos, JA; Pope, BL1
Argentieri, D; Barbone, AG; Lau, CY; Ritchie, D; Wang, EY; Zhou, L1

Other Studies

2 other study(ies) available for tepoxalin and cyclosporine

ArticleYear
Tepoxalin, a novel immunomodulatory compound, synergizes with CsA in suppression of graft-versus-host reaction and allogeneic skin graft rejection.
    Transplantation, 1995, Aug-27, Volume: 60, Issue:4

    Topics: Animals; Cyclosporine; Graft Rejection; Graft Survival; Graft vs Host Reaction; Immunosuppressive Agents; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; NF-kappa B; Pyrazoles; Skin Transplantation

1995
Tepoxalin, a novel immunosuppressive agent with a different mechanism of action from cyclosporin A.
    Journal of immunology (Baltimore, Md. : 1950), 1994, Dec-01, Volume: 153, Issue:11

    Topics: Base Sequence; Cell Line; Cyclosporine; Humans; Immunosuppressive Agents; Interleukin-2; Ionomycin; Lymphocyte Activation; Molecular Sequence Data; Muromonab-CD3; Polymerase Chain Reaction; Pyrazoles; Receptors, Interleukin-2; RNA, Messenger; Signal Transduction; Tetradecanoylphorbol Acetate

1994